Calla® 1452 Virucidal Data

Test Method: * U.S. E.P.A. Pesticide Assessment Guidelines, Subdivision G: Product Performance, Section 91-2 (f), and Section 91-30, (d), (e), November 1982.

 

† Protocols for Testing the Efficacy of Disinfectants against Hepatitis B Virus (HBV) (EPA, Federal Register, Vol. 65, No. 166, 8/25/2000, p. 51828).

 

‡ Protocol for Testing Disinfectants against Hepatitis C Virus using Bovine Viral Diarrhea Virus as approved by the U.S. EPA on August 15, 2002.

 

Test Conditions: 10 minute contact time, 5% organic soil load, sterile glass petri dishes, 400 ppm hard water, 21-24°C exposure temperature, and 4 oz/gal dilution.

 

Results:

 

Test Organism

Sample

Titer Reduction

*Avian Influenza A Virus (H3N2) (Avian Ressortant) (ATCC VR-2072)

A
B

≥4.25 log10
≥4.25 log10

*Avian Influenza Virus, Type A (Turkey/WIS/66) (H9N2)

A
B

≥4.0 log10
≥4.0 log10

*Bovine Rhinotracheitis, strain LA (ATCC VR-188)

A
B

≥5.0 log10
≥5.0 log10

‡Bovine Viral Diarrhea Virus (BVDV)

A
B

5.9 log10
5.9 log10

*Canine Distemper Virus, strain Lederle (ATCC VR-128)

A
B

≥6.25 log10
≥6.25 log10

*Feline Picornavirus, strain FRV (ATCC VR-649)

A
B

≥4.25 log10
≥4.25 log10

†Hepatitis B Virus (HBV) (Duck Hepatitis B Virus-DHBV)

A
B

4.5 log10
4.7 log10

‡Hepatitis C Virus (HCV) (Bovine Viral Diarrhea Virus-BVDV)

A
B

5.9 log10
5.9 log10

*Herpes Simplex Type 1 (ATCC VR-260)

A
B

≥5.0 log10
≥5.0 log10

*Herpes Simplex Type 2 (ATCC VR-734)

A
B

≥6.0 log10
≥6.0 log10

*Human Coronavirus (ATTC VR-740, strain 229E)

A
B

≥3.0 log10
≥3.0 log10

*Human Immunodeficiency Virus, HTLV-IIIRF, strain of HIV-1 (associated with AIDS)

A
B

≥3.5 log10
≥3.5 log10

*Human Immunodeficiency Virus type 2 (HIV-2), strain CBL-20

A
B

≥3.25 log10
≥3.25 log10

*Influenza A2, strain Hong Kong (ATCC VR-544)

A
B

≥4.25 log10
≥4.25 log10

*Pandemic 2009 H1N1 Influenza A Virus

(Refer to NOTE on next page.)

*Paramyxovirus (Mumps) (ATCC VR-1438)

A
B

≥3.0 log10
≥3.0 log10

*Porcine Respiratory & Reproductive Syndrome Virus (PRRSV), strain NVSL

A
B

≥5.0 log10
≥5.0 log10

*Pseudorabies, strain Aujeszky (ATCC VR-135)

A
B

≥5.25 log10
≥5.25 log10

*Rabies Virus (attenuated CDC ERA strain)

A
B

3.0 log10
3.0 log10

*Rotavirus, strain SA-11 (ATCC VR-899)

A
B

4.5 log10
4.5 log10

*SARS Associated Coronavirus (ZeptoMetrix)

A
B

3.03 log10
3.03 log10

*Vaccinia, strain WR (ATCC VR-119)

A
B

≥5.5 log10
≥5.5 log10

 

Conclusions: Under the conditions of this investigation, Calla® 1452 demonstrated virucidal activity against Avian Influenza A Virus (H3N2), Avian Influenza Virus, Type A (H9N2), Bovine Rhinotracheitis, Bovine Viral Diarrhea Virus (BVDV), Canine Distemper Virus, Feline Picornavirus, Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Herpes Simplex Type 1, Herpes Simplex Type 2, Human Coronavirus, Human Immunodeficiency Virus (HIV-1), Human Immunodeficiency Virus Type 2 (HIV-2), Influenza A2, Pandemic 2009 H1N1 Influenza A Virus, Paramyxovirus (Mumps), Porcine Respiratory & Reproductive Syndrome Virus (PRRSV), Pseudorabies, Rabies Virus, Rotavirus, SARS Associated Coronavirus, and Vaccinia, according to criteria established by the U.S. Environmental Protection Agency for registration
and labeling of a disinfectant product as a virucide.

 

NOTE: Per the EPA guidance document dated October 21, 2009, disinfectant products that bear label claims against human, avian, or swine influenza A virus, and have submitted and received approval of efficacy data to support these label claims, may include a label claim against the Pandemic 2009 H1N1 Influenza A Virus.